Similarly, different doses of IL-2 can influence the generation of different T-cell types, with high doses of IL-2 stimulating and generating anti-tumor CTLs, while low doses of IL-2 mainly promote the development and growth of Tregs under resting conditions, ultimately contributing to the formation of immune tolerance [126, 127]. The gene discussed is IL2; the disease is neoplasm.